Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July-August 2020: a mail-based cross-sectional study.
Teah SnyderJohanna RavenhurstEstee Y CramerNicholas G ReichLaura B BalzerDominique AlfandariAndrew A LoverPublished in: BMJ open (2021)
This study fills a critical gap in estimating the levels of subclinical and asymptomatic infection. Estimates can be used to calibrate models estimating levels of population immunity over time, and these data are critical for informing public health interventions and policy.